Systemic sarcoidosis successfully treated with adalimumab: A case report

Dermatol Ther. 2020 May;33(3):e13422. doi: 10.1111/dth.13422. Epub 2020 Apr 30.

Authors

Francisco José Navarro-Triviño¹, María Teresa Muñoz-Valera², José Luis Callejas-Rubio², Norberto Ortego-Centeno²

Affiliations

¹ Department of Contact Eczema and Immunoalergic Diseases, and Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
² Department of Systemic Diseases, Internal Medicine, Hospital Universitario San Cecilio, Granada, Spain.

PMID: 32301191
DOI: 10.1111/dth.13422

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab
Antibodies, Monoclonal, Humanized
Humans
Sarcoidosis* / diagnosis
Sarcoidosis* / drug therapy
Treatment Outcome
Tumor Necrosis Factor-alpha

Substances

Antibodies, Monoclonal, Humanized
Tumor Necrosis Factor-alpha
Adalimumab